Project Grant R43AG076047

Award Date 8/15/22
Completion Date 7/31/24
Dollars Obligated $444K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $608,731 to Brown University to study the impact of Medicare and Medicaid financial policies on post-acute and long-term care utilization and outcomes for persons living with Alzheimer's disease and related dementias (ADRD). The 5-year project aims to leverage Medicare claims and clinical assessment data to examine: 1) changes in nursing home and home health service use by ADRD patients amid...
This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the federal Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program aims to improve long-term care (LTC) quality and safety for individuals living with dementia. With $449,999 in funding, the 3-year project starting September 2024 will implement and evaluate two decision support technology (DS tech) prototypes focused on fall prevention and staff burnout detection in LTC facilities. The...
This five-year, $3,732,394 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) supports a cluster randomized trial to evaluate the effectiveness of the "Palliative Care Education in Assisted Living for Dementia Care Providers" (PCEAL-DCP) intervention. The intervention aims to improve dementia care quality outcomes, including increased documentation of advance care planning discussions and hospice admissions, among 30 assisted living communities...
This Project Grant award of $794,956 from the National Institute on Aging (NIA) Aging Research program (CFDA 93.866) aims to evaluate the effectiveness of Transitional Care Management (TCM) and Chronic Care Management (CCM) services in improving health outcomes and reducing healthcare costs for older adult Medicare beneficiaries. The research will employ a target trial emulation approach to compare TCM and CCM services to usual care, with a focus on outcomes such as home time, survival, and...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This $917,701 federal Project Grant award under the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a 5-year study conducted by Brigham & Women's Hospital to implement and evaluate an Acute Hospital Care at Home (AHCAH) pathway specifically for people living with dementia. The study aims to: 1) Evaluate the effect of a pre-enrollment AHCAH pathway on quality of life over 12 months for persons with moderate to severe dementia (Aim 1); and 2) Evaluate the...
This federal Project Grant award, funded by the National Institute on Aging under CFDA program 93.866 Aging Research, aims to develop and pilot a patient decision aid to support shared decision-making between clinicians, patients, and caregivers regarding pharmacologic therapies for dementia. The $234,000 grant will be awarded to the University of Colorado-Denver and has a project period from September 2024 to August 2026. The key products and services to be delivered through this grant include:...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $584,820 to support a 5-year research study led by Dr. Whitley Aamodt at the University of Pennsylvania. The goal is to improve end-of-life (EOL) care quality for hospitalized patients with Lewy body disorders, a type of Alzheimer's disease and related dementia (ADRD). The project has two key objectives: 1) develop a risk prediction model to identify patients at high risk of 6-month mortality,...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) in the amount of $297,000.00 will support a mixed methods study to understand the challenges and benefits of delivering new Alzheimer's disease (AD) drugs equitably to African American and white patients in Alabama. The objective is to assess access to care barriers, perceived value, and costs and benefits of new AD drugs for these two populations. In the initial R61 planning phase, the University of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $299,893 to Pascall Systems, Inc. to develop a novel system that combines pre-operative cognitive assessment with Pascall's FDA-cleared wireless EEG technology for intraoperative monitoring. The goal is to enable personalized anesthesia care and effective monitoring of postoperative neurocognitive disorders (PNDs) in elderly surgical patients. The key products and services to be delivered...

DEVELOPING A PREPARE FOR YOUR CARE DELIVERY SYSTEM TO ENHANCE ADOPTION BY HEALTHCARE ORGANIZATIONS - PROJECT SUMMARY BACKGROUND: THE POPULATION IS AGING, CHRONIC ILLNESS IS INCREASING, AND MILLIONS OF OLDER ADULTS LACK PREPARATION FOR COMPLEX MEDICAL DECISION MAKING, LEADING TO UNINFORMED DECISIONS AND CARE INCONSISTENT WITH PERSONAL GOALS. THE GOAL OF ADVANCE CARE PLANNING (ACP) IS TO ENSURE THAT PATIENTS RECEIVE MEDICAL CARE ALIGNED WITH THEIR GOALS AND PREFERENCES. OUR TEAM HAS CREATED THE EVIDENCED-BASED, INTERACTIVE ONLINE PREPAREFORYOURCARE.ORG (PREPARE) ACP PROGRAM THAT HELPS ENGLISH AND SPANISH-SPEAKING INDIVIDUALS DEVELOP THE SKILLS TO CLARIFY THEIR VALUES, COMMUNICATE THEIR WISHES, AND MAKE INFORMED MEDICAL DECISIONS. IN TRIALS, PREPARE HELPED 98% OF ENGLISH AND SPANISH-SPEAKING OLDER ADULTS ENGAGE IN ACP AND INCREASED DOCUMENTATION OF ACP DECISIONS IN THE MEDICAL RECORD UP TO 43%. SINCE 2013, PREPARE HAS HAD OVER 350,000 UNIQUE USERS AND THE MATERIALS HAVE BEEN TRANSLATED INTO MULTIPLE LANGUAGES; YET REACH AND ADOPTION BY HEALTHCARE SYSTEMS REMAINS LOW DUE TO BURDENSOME LICENSING AND PURCHASING COMPLEXITY, PACKAGING OF PREPARE MATERIALS THAT MAY NOT MEET ORGANIZATIONS' NEEDS, AND LACK OF GUIDANCE FOR HOW TO INTEGRATE THE MATERIALS INTO CLINICAL WORKFLOWS. THE OBJECTIVE OF THIS PROPOSAL IS TO DEVELOP, REFINE, AND EVALUATE AN ADOPTER-FOCUSED PREPARE DELIVERY SYSTEM (PDS) TO EASE THE PROCESS OF SELECTING, LICENSING, AND IMPLEMENTING PREPARE WITHIN HEALTHCARE ORGANIZATIONS. THE GOAL IS TO IMPROVE ADOPTION AND PROFITABILITY OF PREPARE AND TO POSITION THE TEAM TO APPLY FOR PHASE II SBIR FUNDING TO TEST ADOPTION AND IMPLEMENTATION AMONG VARYING TYPES OF HEALTHCARE AND RELATED ORGANIZATIONS. AIM 1: WE WILL DETERMINE WHAT PREPARE ASSETS (I.E., WEBSITE, ADVANCE DIRECTIVES, PAMPHLETS, VIDEOS), ARE WANTED BY HEALTHCARE ORGANIZATIONS AND HOW ORGANIZATIONS WANT TO ACCESS AND LICENSE THE ASSETS. AIM 2: WE WILL BUILD A PDS PROTOTYPE THAT INCLUDES THE DESIRED ASSETS AND ADDRESSES STAKEHOLDER BARRIERS TO LICENSING AND IMPLEMENTATION. AIM 3: WE WILL DETERMINE THE FEASIBILITY OF THE PDS BY PILOT TESTING AMONG STAKEHOLDER POTENTIAL ADOPTERS. METHODS: WE WILL CONDUCT IN-DEPTH INTERVIEWS WITH HEALTHCARE STAKEHOLDERS FROM A WIDE RANGE OF POTENTIAL ADOPTING ORGANZATIONS INCLUDING COMMUNITY-BASED HOSPITALS, COUNTY HOSPITALS, TERTIARY ACADEMIC MEDICAL CENTERS, AND HEALTHCARE-BASED COMMUNITY ORGANIZATIONS AND ANALYZE THE DATA USING QUALITATIVE CONTENT ANALYSIS (AIMS 1 AND 2). WE WILL ALSO ASSESS FEASIBILITY AND SATISFACTION WITH THE PDS USING VALIDATED SURVEYS AND IN-DEPTH INTERVIEWS (AIM 3). WE HYPOTHESIZE THAT STAKEHOLDERS WILL IDENTIFY PREFERRED PREPARE ASSETS AND BARRIERS TO ADOPTION, CONTINUE TO PROVIDE FEEDBACK ON NEEDED REFINEMENTS OF THE PDS OVER THE COURSE OF DEVELOPMENT, AND REPORT THAT THE PDS IS FEASIBLE AND REPORT HIGH SATISFACTION WITH THE DELIVERAY SYSTEM. RELEVANCE TO NIH AND PUBLIC HEALTH: WIDESPREAD ADOPTION AND IMPLEMENTATION OF THE EVIDENCED-BASED PREPARE PROGRAM MAY REDUCE HEALTH DISPARITIES IN ACP AMONG CULTURALLY AND LINGUISTICALLY DIVERSE OLDER ADULTS. EXPECTED OUTCOMES INCLUDE A FUNCTIONAL PDS PROTOTYPE AND PRELIMINARY DATA TO APPLY FOR PHASE II FUNDING IN WHICH WE WILL FURTHER DEVELOP AND DEPLOY THE PDS AND MEASURE ADOPTION AND DISSEMINATION OF THE PREPARE PROGRAM WITHIN HEALTHCARE SYSTEMS.

Posted 8/5/22